RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an ...

(RTTNews) - Verona Pharma plc (VRNA), Friday announced some strategic changes in its capital structure, increasing the company's financial flexibility ... term loan facility to $450 million ...

Singota Solutions has opened a new facility in Balerna, Switzerland, offering a location touching extensive European ...

RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc ... and amend our term loan facility with Oaktree and OMERS, increasing our financial flexibility and simplifying ...

Read also: Alembic Pharma Karakhadi facility successfully completes USFDA inspection Established in 1990, SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

Recent discoveries and advances in pharma for lower demand illnesses/indications ... but they lack a manufacturing facility that includes quality, technical, and operations support” These ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.